Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Post by jopatcloon Aug 11, 2024 8:25pm
220 Views
Post# 36173770

🫀 STRAIN & 3D 🫀 Our 4th Annual Advanced Imaging Techniques

🫀 STRAIN & 3D 🫀 Our 4th Annual Advanced Imaging Techniques
STRAIN & 3D Our 4th Annual Advanced Imaging Techniques Virtual Experience will be held September 7-8! Register now: bit.ly/3sVhYHJ

It will feature a clinically applicable program aimed at the sonographer/practitioner directly involved in advanced echo imaging.

Course Directors:
Tony Forshaw, M Cardiac Ultrasound, B Ex Sci, AMS (Cardiac), FASE
Cody Frye, BA, ACS, RDCS, FASE
  Advanced Imaging Techniques Virtual Experience The 4th Annual Advanced Imaging Techniques Virtual Experience will be held September 7-8, 2024, and feature a clinically applicable program aimed at the sonographer/practitioner directly involved in advanced echo imaging. A total of 6 CME credits will be available. https://www.asecho.org/advancedtechniques/ Learning Objectives: Recognize the clinical application of advanced echo imaging techniques. Describe the basic principles around strain imaging. Improve acquisition of quality 3D datasets Identify imaging pitfalls affecting acquisition of speckle tracking datasets Perform 3D analysis to assess the left ventricle, right ventricle, & mitral valve during structural interventions Perform strain imaging analysis to assess the left ventricle, right ventricle, & atria.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities